Immune-derived PD-L1 gene expression defines a subgroup of stage II/III colorectal cancer patients with favorable prognosis that may be harmed by adjuvant chemotherapy

Philip D. Dunne, Darragh G. McArt, Paul G. O'Reilly, Helen G. Coleman, Wendy L. Allen, Maurice Loughrey, Sandra Van Schaeybroeck, Simon McDade, Manuel Salto-Tellez, Daniel B. Longley, Mark Lawler, Patrick G. Johnston

Research output: Contribution to journalArticlepeer-review

27 Citations (Scopus)
286 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Immune-derived PD-L1 gene expression defines a subgroup of stage II/III colorectal cancer patients with favorable prognosis that may be harmed by adjuvant chemotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences